Effects of the CYP2C19 LoF Allele on Major Adverse Cardiovascular Events Associated with Clopidogrel in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis is a research paper published in Pharmacogenomics (2022). On theSindex it has a DataRank of 0.505. It has been cited 28 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
Base Score Contribution
0.505
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology βFWCI
2.44
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Supplementary Figures: Effects of CYP2C19 LoF allele on MACE associated with clopidogrel in ACS patients undergoing PCI: Meta-analysis.docx
Supplementary Tables: Effects of CYP2C19 LoF allele on MACE associated with clopidogrel in ACS patients undergoing PCI: Meta-analysis.docx
Supplementary Figures: Effects of CYP2C19 LoF allele on MACE associated with clopidogrel in ACS patients undergoing PCI: Meta-analysis.docx
Supplementary Tables: Effects of CYP2C19 LoF allele on MACE associated with clopidogrel in ACS patients undergoing PCI: Meta-analysis.docx